The United Nations and the urgent need for coordinated global action in the fight against antimicrobial resistance

Annals of Internal Medicine

Volumn 165, Issue 11, 2016, Pages 812-813

  Boucher, Helen W ^a   Bakken, Johan S ^b   Murray, Barbara E ^c  

^a TUFTS MEDICAL CENTER   (United States)

^b St Luke's Medical Office Pavilion   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COLISTIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BENCHMARKING; HUMAN; INFECTION PREVENTION; INVESTMENT; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; SHORT SURVEY; UNITED NATIONS; WORLD HEALTH ORGANIZATION; ANIMAL; COMMUNICABLE DISEASE CONTROL; INAPPROPRIATE PRESCRIBING; INTERNATIONAL COOPERATION;

ANIMALS; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASE CONTROL; DRUG RESISTANCE, BACTERIAL; HUMANS; INAPPROPRIATE PRESCRIBING; INTERNATIONAL COOPERATION; UNITED NATIONS;

EID: 85002931239     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-2079     Document Type: Short Survey

References (10)

1. O'Neill J; Review on Antimicrobial Resistance. Tackling drugresistant infections globally: final report and recommendations. May 2016. Accessed at http://amr-review.org/sites/default/files/160525-Final%20paper-with%20cover.pdf on 25 August 2016.
2. Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, et al; Infectious Diseases Society of America (IDSA). Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011;52 Suppl 5:S397-428. [PMID: 21474585] doi:10.1093/cid/cir153
3. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Accessed at www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf on 25 August 2016.
4. World Health Organization. Antimicrobial resistance: global report on surveillance: 2014. Accessed at http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748-eng.pdf?ua=1 on 25 August 2016.
5. Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. Initial assessments of the National Action Plan for Combating Antibiotic-Resistant Bacteria. March 2016. Accessed at www.hhs .gov/sites/default/files/paccarb-final-report-03312016.pdf on 25 August 2016.
6. Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315: 1864-73. [PMID: 27139059] doi:10.1001/jama.2016.4151
7. Harris AM, Hicks LA, Qaseem A; High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016;164:425-34. [PMID: 26785402] doi:10.7326/M15-1840
8. Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M. Achieving global targets for antimicrobial resistance. Science. 2016; 353:874-5. [PMID: 27540009] doi:10.1126/science.aaf9286
9. McGann P, Snesrud E, Maybank R, Corey B, Ong AC, Clifford R, et al. Escherichia coli Harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States [Letter]. Antimicrob Agents Chemother. 2016;60:4420-1. [PMID: 27230792] doi:10 .1128/AAC.01103-16
10. Abbasi J. Infectious disease expert sees threat from colistinresistant superbug. JAMA. 2016;316:806-7. [PMID: 27464338] doi: 10.1001/jama.2016.9690